Welcome to CDC stacks | Prevalence of hypothyroidism among MDR-TB patients in Botswana - 41904 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevalence of hypothyroidism among MDR-TB patients in Botswana
Filetype[PDF-269.88 KB]


No Related Documents.
You May Also Like:
  1. Drug-Induced Hypothyroidism during Anti-Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Notes from the Field
    Personal Author:
    Munivenkatappa, Somashekar; Anil, Singarajipura; Naik, Balaji; Volkmann, Tyson; Sagili, Karuna D.; Akshatha, Jayachamarajapura S.; Buggi, Shashidhar; Sharada, Manchenahalli A.; Kulkarni, Sudhendra; Chadha, Vineet K.; Moonan, Patrick K.;
    Published:
    Aug 23 2016
    Source:
    J Tuberc Res. 4(3):105-110.
    Description:
    We followed 188 euthyroidic persons undergoing treatment for multidrug resistant tuberculosis (MDR-TB) in the state of Karnataka, India to determine the incidence of hypothyroidism during anti-tuberculosis treatment. Overall, among MDR-TB patients wi...
    File Type:
    Filetype[PDF - 56.04 KB]
  2. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey
    Personal Author:
    Menzies, H. J.; Moalosi, G.; Anisimova, V.; Gammino, V.; Sentle, C.; Bachhuber, M. A.; Bile, E.; Radisowa, K.; Kachuwaire, O.; Basotli, J.; Maribe, T.; Makombe, R.; Shepherd, J.; Kim, B.; Samandari, T.; El-Halabi, S.; Chirenda, J.; Cain, K. P.;
    Published:
    Sep 2014
    Source:
    Int J Tuberc Lung Dis. 18(9):1026-1033.
    Description:
    SETTING : Although approximately 0.5 million cases of multidrug-resistant tuberculosis (MDR-TB) occur globally each year, surveillance data are limited. Botswana is one of the few high TB burden countries to have carried out multiple anti-tuberculosi...
    File Type:
    Filetype[PDF - 604.13 KB]
  3. International Research and Programs Branch annual report 2010
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination. International Research and Programs Branch.
    Published:
    10/19/2011
    Description:
    The U.S. Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination (DTBE), International Research and Programs Branch (IRPB) has worked closely with Ministries of Health (MOH) for more than 30 years, strengthening capacit...
    File Type:
    Filetype[PDF - 2.43 MB]
  4. Protocol for a population-based molecular epidemiology study of tuberculosis transmission in a high HIV-burden setting: the Botswana Kopanyo study
    Personal Author:
    Zetola, N M; Modongo, C; Moonan, P K; Click, E; Oeltmann, J E; Shepherd, J; Finlay, A;
    Published:
    May 09 2016
    Source:
    BMJ Open. 2016; 6(5).
    Description:
    Introduction : Mycobacterium tuberculosis (Mtb) is transmitted from person to person via airborne droplet nuclei. At the community level, Mtb transmission depends on the exposure venue, infectiousness of the tuberculosis (TB) index case and the susce...
    File Type:
    Filetype[PDF - 1.37 MB]
  5. Underreported Threat of Multidrug-Resistant Tuberculosis in Africa
    Personal Author:
    Ben Amor, Yanis; Nemser, Bennett; Singh, Angad; Sankin, Alyssa; Schluger, Neil;
    Published:
    Sep 2008
    Source:
    Emerg Infect Dis. 14(9):1345-1352.
    Description:
    Multidrug-resistant tuberculosis (MDR TB) in Africa may be more prevalent than previously appreciated. Factors leading to development of drug resistance need to be understood to develop appropriate control strategies for national programs. We gathere...
    File Type:
    Filetype[PDF - 184.78 KB]